A stroke is not a cardiac event. It is a cerebrovascular event, meaning it happens in the blood vessels supplying the brain, not in the heart muscle itself. But the two are so deeply intertwined that separating them cleanly is harder than it sounds. The heart can cause strokes, strokes can damage the heart, and both conditions share an overlapping web of risk factors. The American Heart Association publishes its annual stroke data in the same statistical report as heart disease, which adds to the public’s understandable confusion.
Why People Confuse Strokes With Heart Attacks
The confusion is not just a matter of ignorance. Strokes and heart attacks are both caused by disrupted blood flow, and the underlying conditions that set them up often look similar on paper. High blood pressure, diabetes, and atrial fibrillation are among the most common risk factors for acute stroke, and each of those is also a major player in heart disease.1PubMed Central. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke The American Heart Association’s flagship statistical update covers heart disease and stroke side by side, listing stroke alongside coronary heart disease, heart failure, arrhythmias, and other circulatory conditions in a single annual report.2Circulation. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association When you see “cardiovascular disease” in a headline, it usually includes stroke in the count. That institutional grouping makes practical sense for prevention campaigns, but it blurs the line for the public.
Research on people who have actually had strokes shows how deep the confusion runs. Many stroke survivors did not initially realize their symptoms were stroke-related. In qualitative interviews, patients described having “no idea” what was happening and not recognizing the experience as a stroke because it did not match their expectations.3BMJ. Perceptions of stroke in the general public and patients with stroke: a qualitative study If people who have had strokes struggle to identify them, it is no surprise that the general public lumps strokes in with heart attacks.
How the Heart Causes Strokes
While a stroke is not a cardiac event, a cardiac event can absolutely cause a stroke. The most direct route is cardioembolic stroke, which accounts for a substantial share of all ischemic strokes. Here, a blood clot forms inside the heart and then breaks free, travels through the arteries, and lodges in a blood vessel in the brain. Atrial fibrillation is the leading driver. The irregular rhythm allows blood to pool and stagnate, especially in a small pouch called the left atrial appendage. That stagnation encourages clot formation. When a clot dislodges, it can reach the brain within seconds.4PubMed Central. Mechanisms and treatment of atrial fibrillation and stroke
Heart failure adds another layer of risk. When the heart’s pumping ability drops, the sluggish blood flow creates conditions favorable for clots. A reduced pumping fraction, measured as left ventricular ejection fraction of 40% or below, is a known risk factor for ischemic stroke even when atrial fibrillation is not present.5PubMed Central. Anticoagulants for stroke prevention in heart failure with reduced ejection fraction This is worth knowing because anticoagulant therapy, which works well for stroke prevention in atrial fibrillation, has not proven effective in heart failure patients with normal rhythm. In those patients, the increased bleeding risk from blood thinners outweighed the stroke-prevention benefit.5PubMed Central. Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
The Patent Foramen Ovale Problem
There is a structural heart defect that offers a less obvious route for stroke. A patent foramen ovale, or PFO, is a small flap-like opening between the left and right upper chambers of the heart. Everyone has one before birth, and in most people it closes shortly after. But in roughly a quarter of the general population it remains open. That opening is usually harmless. The problem arises when a blood clot from elsewhere in the body, typically the veins in the legs, passes through the PFO and reaches the brain instead of being filtered by the lungs. This is called paradoxical embolism.
PFO prevalence climbs to as high as 40% in patients who have had a stroke with no identifiable cause, known as cryptogenic stroke, suggesting it is far more than an incidental finding.6PubMed Central. Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention Roughly half of patients with cryptogenic stroke have a PFO.7PubMed. Cryptogenic Stroke and Patent Foramen Ovale Randomized trials have shown that closing the PFO with a catheter-based device significantly reduces the risk of another stroke compared with medication alone, at least in well-selected patients. PFO closure is now a standard option for younger stroke patients when no other cause is found.8PubMed. Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence This is a case where fixing a heart problem directly prevents a brain problem, which makes the boundary between “cardiac” and “cerebrovascular” feel artificial.
Shared Plumbing, Different Failure Modes
Atherosclerosis, the buildup of fatty plaque in artery walls, is the common villain in both coronary heart disease and a major subtype of ischemic stroke. But it does not behave identically in the arteries that feed the heart and those that feed the brain. In the coronary arteries, heart attacks are usually triggered by a plaque that ruptures or erodes, forming a clot on the spot. The degree of narrowing before that happens is not very predictive of which plaques will cause trouble. In the carotid arteries, by contrast, severe narrowing itself is a strong predictor of stroke because it reduces blood flow to the brain.9Atherosclerosis. Coronary and carotid atherosclerosis: Similarities and differences The two arteries also differ in how effectively the body builds backup blood routes around blockages.
This distinction matters for screening. Coronary artery calcium scoring, a CT-based measure of plaque in the heart’s arteries, is a strong predictor of heart attacks but less useful for predicting stroke on its own. Carotid artery wall thickness, measured by ultrasound, has a somewhat stronger relationship to stroke risk, particularly in older adults.10PubMed Central. Coronary artery calcium, carotid artery wall thickness, and cardiovascular disease outcomes in adults 70 to 99 years old Neither test adds much predictive power for stroke beyond what traditional risk factors like blood pressure and cholesterol already provide.11PubMed Central. Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis So even though the same disease process underlies both conditions, the tools for catching it early do not transfer one-to-one.
Hemorrhagic Stroke Is a Different Animal Entirely
Everything discussed so far mostly applies to ischemic stroke, where a blocked artery starves part of the brain of blood. But about 15% of strokes are hemorrhagic, caused by a ruptured blood vessel bleeding into or around the brain. Hemorrhagic stroke has a strikingly different risk profile from both ischemic stroke and coronary heart disease. In a large study comparing risk factors in women, higher non-HDL cholesterol raised the risk of coronary heart disease but actually appeared to lower the risk of hemorrhagic stroke.12PubMed Central. Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women Blood pressure and markers of inflammation also had significantly different relationships with hemorrhagic versus ischemic outcomes. The researchers concluded that the two stroke types have substantially different biology.
This is one of the reasons treating stroke and heart disease as a single bundle can be misleading. Aggressive cholesterol lowering, a cornerstone of heart attack prevention, does not help and may theoretically hurt when it comes to hemorrhagic stroke. The prevention strategies that make sense for each condition diverge in important ways, even though the top-line risk factor (high blood pressure) is shared.
When a Stroke Damages the Heart
The relationship does not only run from heart to brain. Strokes, especially severe ones, can injure the heart directly. A surge of stress hormones triggered by the brain injury can stun the heart muscle, a phenomenon called neurogenic stunned myocardium. The resulting damage can mimic an acute heart attack on cardiac tests and imaging, even when the coronary arteries are completely clean.13PubMed Central. A Review of Neurogenic Stunned Myocardium This is part of a broader set of complications known as the stroke-heart syndrome, which also includes sudden cardiac death and Takotsubo syndrome, a stress-induced ballooning of the heart that can look frighteningly like a heart attack.14PubMed. Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review
Strokes affecting a specific area of the brain called the right insular cortex are particularly dangerous for the heart. That region helps regulate the autonomic nervous system, which controls heart rate and rhythm. Damage there is associated with reduced heart rate variability and more complex cardiac arrhythmias compared with strokes in other locations.15PubMed. Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement In other words, depending on where in the brain the stroke hits, the heart can become an immediate casualty.
The Troponin Puzzle After Stroke
When someone has a stroke and blood tests show elevated troponin, a protein released by damaged heart muscle cells, the medical team faces a tricky question: is this a concurrent heart attack, or is the brain injury itself causing the heart damage? Research suggests the answer is usually the latter. In a study that took stroke patients with elevated troponin levels straight to coronary angiography, culprit lesions (the kind of blockages that cause acute heart attacks) were significantly less common than in heart attack patients with similar troponin levels. Half of the stroke patients had no angiographic evidence of coronary artery disease at all.16PubMed. Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac Troponin: The Troponin Elevation in Acute Ischemic Stroke (TRELAS) Study
Troponin T is considered the more specific marker for this kind of neurogenic cardiac injury, outperforming other cardiac enzymes in distinguishing true heart damage from other causes.17PubMed Central. Elevated troponin in patients with acute stroke – Is it a true heart attack? This distinction matters enormously for treatment. If the troponin rise reflects an actual heart attack, the patient may need urgent cardiac intervention. If it is neurogenic, rushing to the catheterization lab could delay stroke treatment and expose the patient to unnecessary risk.
Why Cardiac Monitoring Matters After a Stroke
Even when a stroke does not damage the heart, uncovering what caused the stroke often requires extended cardiac monitoring. Many strokes are cryptogenic, meaning no clear cause is identified during the initial workup. A significant portion of those turn out to be caused by atrial fibrillation that was not detected because the irregular rhythm comes and goes. The standard 24-hour heart monitor catches only a fraction of these cases.
A landmark trial found that an implantable heart monitor detected atrial fibrillation lasting 30 seconds or longer in about 16% of cryptogenic stroke patients, compared with just 3% detected by conventional monitoring.18PubMed. Atrial Fibrillation in Patients with Cryptogenic Stroke That is a five-fold increase in detection, and the patients whose atrial fibrillation was found were significantly more likely to be started on anticoagulant therapy, which is the proven way to prevent further strokes from this cause. Evidence strongly supports monitoring for at least 72 hours rather than the traditional 24, though the ideal duration beyond that remains debated.19PubMed Central. Optimal Duration of Monitoring for Atrial Fibrillation in Cryptogenic Stroke: A Nonsystematic Review Outpatient telemetry picks up atrial fibrillation in a substantial proportion of cryptogenic stroke patients who would otherwise go undiagnosed.20PubMed. Predictors of finding occult atrial fibrillation after cryptogenic stroke
Cardiac Procedures That Carry Stroke Risk
If heart conditions can cause strokes, it follows that procedures performed on the heart can too. Any intervention that involves the heart’s chambers, valves, or major vessels creates an opportunity for debris or clots to reach the brain. Among common cardiac procedures, transcatheter aortic valve replacement (TAVR) carries one of the higher stroke rates. A large national analysis found a 90-day ischemic stroke readmission rate of about 2% after TAVR, which was nearly double the rate seen after traditional surgical valve replacement.21PubMed Central. Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set
Stroke after TAVR occurs in three distinct phases: a high-risk period immediately during and after the procedure, an elevated-risk window during the first month, and a later period driven by different causes such as new-onset atrial fibrillation or progression of atherosclerosis.22PubMed Central. Managing Stroke During Transcatheter Aortic Valve Replacement Devices designed to catch debris released during the procedure, known as cerebral protection devices, have shown a modest benefit. A large analysis found they did not significantly reduce overall stroke rates but did lower the rate of major strokes.23PubMed Central. Outcomes and Predictors of Stroke After Transcatheter Aortic Valve Replacement in the Cerebral Protection Device Era Patients who had prior valve surgery faced the highest stroke risk of any subgroup.
The Bidirectional Genetic Link
Recent genetic research has tried to untangle whether the connection between stroke and heart attack runs deeper than just shared risk factors. A study using a method that harnesses natural genetic variation to test causal relationships found that the subtype of ischemic stroke caused by large-artery atherosclerosis was causally linked to a higher risk of heart attack, with odds roughly 13% higher per unit of genetic liability.24PubMed Central. Stroke and Myocardial Infarction: A Bidirectional Mendelian Randomization Study Heart attack, in turn, was genetically correlated with ischemic stroke, and the association was strongest with the large-artery subtype. But when the researchers accounted for genetic variants that influence both conditions through shared pathways like blood pressure or cholesterol, the reverse causal direction (heart attack causing stroke) lost statistical significance. The relationship is real but not symmetrical: the genetic architecture of large-artery stroke appears to drive heart attack risk more than the other way around.
Sex-Specific Differences in Risk
The overlap between heart and brain risk is not identical in men and women. Premenopausal women have a lower stroke risk than men of the same age, an advantage attributed in part to estrogen’s effects on blood vessel health, lipid metabolism, and coagulation. After menopause, that protection fades. Estrogen loss alters lipid profiles, reduces anti-inflammatory effects, and accelerates biological aging, which converges into a rising stroke risk for women in their late 60s and beyond.25PubMed Central. Gender Predicts Differences in Acute Ischemic Cardioembolic Stroke Profile: Emphasis on Woman-Specific Clinical Data and Early Outcome—The Experience of Sagrat Cor Hospital of Barcelona Stroke Registry Gender-specific differences in cardioembolic stroke largely disappear between ages 65 and 84 but re-emerge in the oldest age group, where women face a greater burden of morbidity. For women, the interplay between cardiac and cerebrovascular risk shifts meaningfully across the lifespan in a way that does not apply to men.
Statins and the Prevention Overlap
Prevention strategies for heart disease and stroke overlap but are not interchangeable. Statins, the workhorse drugs for lowering cholesterol and preventing heart attacks, also reduce stroke risk, but the magnitude is different. In patients with established coronary heart disease, statins prevented about 9 strokes per 1,000 patients treated over five years, compared with roughly 17 prevented by antiplatelet drugs and a similar number by blood pressure medications.26The Lancet Neurology. Statins for stroke prevention In other words, statins are a meaningful part of stroke prevention but contribute less than blood pressure control and antiplatelet therapy. For a patient trying to understand why their doctor prescribed a statin after a stroke, the answer is that it helps, but it is not the main event. The main event is controlling blood pressure.
This ordering of priorities makes sense given what we know about hemorrhagic stroke’s inverted relationship with cholesterol levels. Aggressive cholesterol reduction benefits the ischemic side of the equation but does nothing for, and might theoretically worsen, hemorrhagic risk. Blood pressure lowering helps prevent both types. That is why hypertension control remains the single most impactful intervention across the full spectrum of stroke and heart disease.
When a Stroke Patient Needs a Cardiologist
A reduced left ventricular ejection fraction discovered during a stroke hospitalization is both a clue to the stroke’s cause and a red flag for future cardiac events and recurrent strokes.27PubMed. Ischemic Stroke and Reduced Left Ventricular Ejection Fraction: A Multidisciplinary Approach to Optimize Brain and Cardiac Health Stroke units increasingly involve cardiologists early, not just to manage heart complications but to investigate whether a heart condition caused the stroke in the first place. The workup typically includes echocardiography to check heart structure and function, extended rhythm monitoring to catch atrial fibrillation, and sometimes bubble studies to detect a PFO. What starts as a neurological emergency often becomes a cardiology case within days.
This multidisciplinary reality is the clearest answer to the title question. A stroke is not classified as a cardiac event, and the treatment algorithms differ in important ways. But the two organ systems are so tightly linked that managing one without investigating the other leads to missed diagnoses and preventable recurrences. The medical field increasingly treats stroke and heart disease as two chapters of the same story, even if they occupy different pages in the textbook.